Skip to main content

Mizrahi Jews

 Mizrahi Jewish GeneticsMizrahi Jews (from Hebrew "Mizraḥ," meaning "East") are descendants of Jewish communities in the Middle East and North Africa, including regions like Iraq, Iran, Yemen, Syria, Egypt, and Morocco. They form a significant portion of the global Jewish population (10-15%, or ~1.5-2 million people), with the largest communities today in Israel (1.5 million, often overlapping with Sephardic communities due to shared cultural and genetic histories). Unlike Ashkenazi Jews, who have more uniform genetic ancestry due to historical bottlenecks, Mizrahi Jews are genetically diverse, reflecting centuries of residence in varied regions and some intermarriage with local populations. Below is a detailed breakdown of their genetic profile, informed by studies like those from the Human Genome Diversity Project, Israeli biobanks, and recent genomic research (e.g., Behar et al., 2010; Atzmon et al., 2010).Genetic AncestryLevantine Core: Mizrahi Jews share ~50-70% ancestry with other Jewish groups, tracing back to ancient Israelite populations in the Levant (modern Israel, Lebanon, Syria). This is evident in shared Y-chromosomal haplogroups (e.g., J1, J2) and mitochondrial DNA (mtDNA) lineages (e.g., K, H) linked to Middle Eastern origins.

Regional Admixture: Depending on their geographic diaspora, Mizrahi Jews show admixture with local populations:Iraqi/Iranian Jews: ~20-30% Mesopotamian/Persian ancestry; genetically close to Assyrian Christians and Kurds. Common haplogroups: J1 (paternal, ~30%), HV (maternal, ~20%).

Yemenite Jews: 30-40% South Arabian admixture; unique due to isolation in the Arabian Peninsula. High prevalence of J1 (50%) and mtDNA L lineages (~10-15%, shared with local Arabs).

North African (Maghrebi) Jews: 20-30% Berber/Arab ancestry; overlap with Sephardic Jews post-1492 expulsion. Common haplogroups: E1b1b (25%, shared with Berbers), mtDNA H (~25%).

Syrian/Lebanese Jews: Closer to Levantine Arabs and Druze (30% admixture); high J2 (25%) and mtDNA K (~20%).

Less Bottlenecking: Unlike Ashkenazi Jews, who underwent severe population bottlenecks (~350 effective founders), Mizrahi groups maintained larger effective population sizes, leading to greater genetic diversity. This reduces the prevalence of founder-effect disorders compared to Ashkenazim.

Shared Jewish Markers: All Mizrahi groups show Cohen Modal Haplotype (CMH, within J1 haplogroup) at elevated rates (~15-20% in males), suggesting shared priestly lineage with other Jews. Autosomal studies confirm ~40-60% shared ancestry with Ashkenazi and Sephardic Jews, higher than with non-Jewish neighbors.

Genetic DisordersDue to less endogamy and larger founding populations, Mizrahi Jews have fewer population-specific recessive disorders than Ashkenazim but share some region-specific conditions with local non-Jews:Familial Mediterranean Fever (FMF): Common in Iraqi, Syrian, and North African Jews (~1:5-10 carriers); caused by MEFV gene mutations; also prevalent in Arabs, Turks, and Armenians.

Beta-Thalassemia: Elevated in North African and Iraqi Jews (~1:20-30 carriers); overlaps with Mediterranean populations (e.g., Greeks, Arabs).

Glucose-6-Phosphate Dehydrogenase Deficiency (G6PD): High in Iraqi, Iranian, and Yemenite Jews (~1:10-20 males); linked to malaria resistance, shared with local Arabs.

Lower Ashkenazi-Linked Disorders: Tay-Sachs, Gaucher, or BRCA1/2 mutations are rare in Mizrahi populations, reflecting different founder effects.

Screening Efforts: Israel’s genetic screening programs (e.g., Dor Yeshorim) include Mizrahi-specific panels, but diversity complicates universal testing compared to Ashkenazi-focused efforts.

COVID-19 and Mizrahi GeneticsRegarding the user’s context (RFK Jr.’s and Tucker Carlson’s claims about Jewish “immunity” to COVID-19), no genetic studies support Mizrahi-specific resistance or susceptibility to SARS-CoV-2. The 2020 Hou et al. study (BMC Medicine) cited by RFK Jr. focused on Ashkenazi Jews and Amish, not Mizrahi or Sephardic groups, and only speculated about ACE2 receptor variants without clinical confirmation. In Israel, where Mizrahi Jews are a significant demographic, COVID-19 outcomes correlated with socioeconomic factors (e.g., crowded housing, healthcare access) rather than genetics. For example:Mixed Mizrahi/Sephardic communities in Israel’s “periphery” (e.g., southern towns like Beersheba) had infection rates (10-15% in 2020-2021) lower than ultra-Orthodox Ashkenazi communities (31%) but higher than Bedouin areas (~5-7%), driven by urban density and vaccine uptake.

No peer-reviewed data supports differential impacts between Mizrahi and other Jewish groups; claims like those from Andrew Huff (Carlson’s guest) lack specific evidence.

Key Comparisons with Ashkenazi and Sephardic JewsAshkenazi Jews: 50-60% Middle Eastern, 30-40% European ancestry; tighter bottleneck (350 founders); higher prevalence of disorders like Tay-Sachs, BRCA1/2. Genetically more uniform; ~30% autosomal overlap with Mizrahi Jews.

Sephardic Jews: ~60-70% Middle Eastern/North African, 20-30% Iberian ancestry; more diverse than Ashkenazim but less than Mizrahim. Overlap with Maghrebi Mizrahi Jews (e.g., Moroccan Jews); share FMF and beta-thalassemia risks.

Mizrahi Jews: Most diverse; ~50-70% Middle Eastern, 20-40% regional admixture (Arab, Persian, Berber). Fewer founder-effect disorders; genetically closer to local Middle Eastern/North African populations than Ashkenazim are to Europeans.

Modern Insights and ResearchGenomic Studies: Behar et al. (2010) and Ostrer et al. (2013) used autosomal DNA to confirm Mizrahi Jews’ Levantine core with regional admixture. 23andMe and MyHeritage data show Mizrahi Jews clustering between Ashkenazi/Sephardic and Middle Eastern populations (e.g., Druze, Palestinians).

Population Dynamics: Intermarriage in Israel (~25% of Jewish marriages are Ashkenazi-Mizrahi/Sephardic) is reducing genetic distinctions, creating a more mixed “Israeli Jewish” profile.

Health Applications: Israel’s Clalit Health Services and Hadassah Medical Center run biobanks to study Mizrahi genetics, focusing on FMF and cancer predispositions. Polygenic risk scores for diseases like diabetes are being tailored to Mizrahi diversity.

Limitations and NotesData Gaps: Less genetic research exists on Mizrahi Jews compared to Ashkenazim due to their diversity and smaller diaspora populations. Yemenite and Iranian Jews are particularly understudied.

Cultural Overlap: In Israel, “Sephardic” and “Mizrahi” are often conflated (e.g., Moroccan Jews are both), complicating genetic categorization.

Misinformation Risk: Claims of ethnic-specific COVID-19 immunity (e.g., RFK Jr., Huff) lack evidence and risk fueling stereotypes. Always verify with primary sources like PubMed or Israeli health data.

If you want specific studies, X post analysis, or a deeper dive into a Mizrahi subgroup (e.g., Yemenite or Iraqi Jews), let me know!

Comments

Post a Comment

Popular posts from this blog

Tucker anti western propoganda

 Tucker's Qatar Claim: Fact-Checking the "Zero Rapes" MythTucker Carlson recently claimed on his podcast (August 2025) that Qatar has "zero rapes" under Sharia law, using it to argue that Islamic legal systems outperform Western democracies in maintaining order. During an interview with Seth Harp, he praised Sharia for low reported crime, low abortion rates, and no same-sex marriage—positioning it as a model for conservatives frustrated with American liberalism.This is propaganda wrapped in contrarianism—cherry-picked stats that ignore harsh realities. Here’s the breakdown:The Claim's Flaw: "Zero Rapes" Isn't Safety—It's SuppressionOfficial stats vs. reality: Qatar reports near-zero rapes because Sharia-based laws make reporting dangerous for victims. Rape requires four male Muslim witnesses (or a confession), or it's treated as zina (adultery/fornication). Women who report assault often face imprisonment, flogging, or worse for "e...
Post a Comment
Read more

Qatar Anti-Anerican funding

  Qatar's Spending Overview Qatar, a major Gulf state with significant oil and gas revenues, channels funds through government entities like the Qatar Fund for Development (QFFD), Qatar Foundation, and state-linked charities (e.g., Qatar Charity). These often support humanitarian, educational, and political goals but have drawn criticism for advancing Qatari foreign policy interests, including ties to Islamist groups like the Muslim Brotherhood and Hamas. Below, I break down spending in the requested categories based on public reports, FARA (Foreign Agents Registration Act) filings, U.S. Department of Education disclosures, and analyses from think tanks like ISGAP and the Middle East Forum. Figures are approximate and cumulative where specified; recent years (2023–2025) show acceleration amid the Israel-Hamas conflict. 1. Funding to American Colleges Qatar is the largest foreign donor to U.S. higher education, primarily via the Qatar Foundation (a state-controlled entity) for branc...
Post a Comment
Read more

EU and X

 LEFT WING RESEARCHERS WANT TO LIMIT RIGHT WING DIALOGE! The EU's DSA requirement for researcher data access (Article 40) gives "vetted" researchers—typically academics or non-profits approved by national regulators—easier access to public X data like post engagement, views, and networks. The official goal is studying "systemic risks" (e.g., disinformation spread). Critics argue this can chill or deter honest/open dialogue in these ways:Broad and subjective labeling of "disinformation" or "harmful" speech: Researchers studying political topics can flag dissenting or unpopular views (e.g., on immigration, elections, gender issues, or COVID policies) as "misinformation" if they don't align with mainstream narratives, leading to reports that pressure platforms or governments to suppress them. Doxxing and harassment risks: Detailed data (e.g., who engages with controversial posts) can reveal user networks or identities, even if post...
Post a Comment
Read more